Ayala Pharmaceuticals Inc (ADXS)

[mm2k]

How did they get this far into the trial with a manufacturing problem, wouldn't they have to disclose something like that? I'm probably wrong, but this doesn't add up to me, is it possible that they see HOT as being almost as effective as NEO but having better manufacturability, and thus are bailing out on NEO? Maybe the manufacturing problem is just a cost problem? It's a stretch, I know.